antisense oligonucleotide , McGill (ARC)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameantisense oligonucleotide , McGill (ARC)
Drug Alias Nameanticancer antisensie oligonucleotide (McGill/ARC Pharmaceutical)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMcGill University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesARC Pharmaceuticals IncMcGill University
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A